跳至主要内容
临床试验/NCT00828425
NCT00828425已完成不适用

Management of Diabetes Mellitus Patients With Retinopathy

AstraZeneca1 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2008年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
2,500
试验地点
1
主要终点
Blood lipids, glycemia, HbA1C, blood creatinine, proteinuria, body weight

研究概览

简要总结

Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed:

  • which medication are used to keep blood pressure under control?
  • which medication are used for metabolic control?
  • the average control level of metabolism and blood pressure is compliant with the international guidelines?
  • laser photocoagulation plays a role in the control of metabolism and blood pressure?
  • there are differences in the control of metabolism and blood pressure between patients with DM I or DM II?
  • there is an influence of renal failure on the choose of medication?

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Diabetic patients
  • Diabetic retinopathy

排除标准

  • 未提供

结局指标

主要结局

Blood lipids, glycemia, HbA1C, blood creatinine, proteinuria, body weight

时间窗: every 3 months

evolution of diabetic retinopathy

时间窗: every 3 months

次要结局

  • concomitant medication(every 3 months)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Management of Diabetes Mellitus Patients With... | 临床试验